Skip to main content
TipRanks
Go Ultimate75% OFF

Basel Medical Group Ltd (BMGL) Stock Statistics & Valuation Metrics

87 Followers

Total Valuation

Basel Medical Group Ltd has a market cap or net worth of $5.20M. The enterprise value is $14.81T.

Market Cap
$5.20M
Enterprise Value
$14.81T

Share Statistics

Basel Medical Group Ltd has 13,582,111 shares outstanding. The number of shares has decreased by 94.24% in one year.

Shares Outstanding
13,582,111
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

Basel Medical Group Ltd’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is 58.87%.

Return on Equity (ROE)
-0.15
Return on Assets (ROA)
-0.04
Return on Invested Capital (ROIC)
58.87%
Return on Capital Employed (ROCE)
1.05
Revenue Per Employee
290.71K
Profits Per Employee
-10.11K
Employee Count
74
Asset Turnover
1.21
Inventory Turnover
57.04

Valuation Ratios

The current PE Ratio of Basel Medical Group Ltd is -0.70. Basel Medical Group Ltd’s PEG ratio is -0.01.

PE Ratio
-0.70
PS Ratio
0.03
PB Ratio
0.11
Price to FCF
-0.45
Price to Operating Cash Flow
-0.37
PEG Ratio
-0.01

Income Statement

In its last fiscal year, Basel Medical Group Ltd had revenue of 21.51M and earned -748.00K in profits. Earnings per share was -0.48.

Revenue
21.51M
Gross Profit
8.34M
Operating Income
8.33M
Pretax Income
-1.25M
Net Income
-748.00K
EBITDA
-439.83K
Earnings Per Share (EPS)
-0.48

Cash Flow

In the last 12 months, operating cash flow was -1.44M and capital expenditures -310,234, giving a free cash flow of -1.75M.

Operating Cash Flow
-1.44M
Free Cash Flow
-1.75M
Free Cash Flow per Share
-1.62

Dividends & Yields

Basel Medical Group Ltd pays an annual dividend of ―, resulting in a dividend yield of ―.

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-224.32%
Earnings Yield
-114.85%

Stock Price Statistics

Beta
0.19
52-Week Price Change
-97.41%
50-Day Moving Average
3.69
200-Day Moving Average
6.00
Relative Strength Index (RSI)
19.85
Average Volume (3m)
2.59M

Financial Position

Basel Medical Group Ltd has a current ratio of 1.23, with a Debt / Equity ratio of 190.24%.

Current Ratio
1.23
Quick Ratio
1.21
Debt to Market Cap
1.12
Net Debt to EBITDA
-20.67
Interest Coverage Ratio
18.12

Taxes

In its last fiscal year, Basel Medical Group Ltd paid 179.56K in taxes.

Income Tax
179.56K
Effective Tax Rate
-0.14

Enterprise Valuation

Basel Medical Group Ltd EV to EBITDA ratio is -724.69, with an EV/FCF ratio of -5.63.

EV to Sales
0.39
EV to EBITDA
-724.69
EV to Free Cash Flow
-5.63
EV to Operating Cash Flow
-6.84

Balance Sheet

Basel Medical Group Ltd has $529.89K in cash and marketable securities with $9.62M in debt, giving a net cash position of -$9.09M.

Cash & Marketable Securities
$529.89K
Total Debt
$9.62M
Net Cash
-$9.09M
Net Cash Per Share
-$0.67
Tangible Book Value Per Share
$4.19

Margins

Gross margin is 27.23%, with operating margin of 19.67%, and net profit margin of -2.40%.

Gross Margin
27.23%
Operating Margin
19.67%
Pretax Margin
-4.24%
Net Profit Margin
-2.40%
EBITDA Margin
-0.05%
EBIT Margin
-9.08%

Analyst Forecast

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
49.87%
EPS Growth Forecast
92.79%